Ensign Peak Advisors
HCAT icon

Ensign Peak Advisors’s Health Catalyst HCAT Stock Holding History

Ensign Peak Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-456,841
Closed -$4.23M – 1731
2023
Q4 		$4.23M Buy
456,841
+85,285
+23% +$697K 0.01% 668
2023
Q3 		$3.76M Sell
371,556
-324,035
-47% -$3.87M 0.01% 651
2023
Q2 		$8.69M Buy
695,591
+26,987
+4% +$321K 0.02% 454
2023
Q1 		$7.8M Buy
668,604
+24,560
+4% +$313K 0.02% 459
2022
Q4 		$6.85M Sell
644,044
-143,107
-18% -$1.38M 0.02% 485
2022
Q3 		$7.63M Buy
787,151
+431,939
+122% +$5.72M 0.02% 425
2022
Q2 		$5.15M Buy
355,212
+145,204
+69% +$2.48M 0.01% 527
2022
Q1 		$5.49M Sell
210,008
-280,148
-57% -$7.95M 0.01% 564
2021
Q4 		$19.4M Buy
490,156
+739
+0.2% +$33.7K 0.04% 325
2021
Q3 		$24.5M Buy
489,417
+166,143
+51% +$9.06M 0.05% 283
2021
Q2 		$17.9M Sell
323,274
-3,841
-1% -$205K 0.04% 331
2021
Q1 		$15.3M Sell
327,115
-6,230
-2% -$302K 0.03% 351
2020
Q4 		$14.5M Buy
333,345
+34,280
+11% +$1.26M 0.03% 364
2020
Q3 		$10.9M Buy
299,065
+12,324
+4% +$419K 0.03% 425
2020
Q2 		$8.36M Buy
286,741
+36,582
+15% +$1.01M 0.02% 465
2020
Q1 		$6.54M Buy
250,159
+38,812
+18% +$1.19M 0.02% 449
2019
Q4 		$7.33M Buy
+211,347
New +$7M 0.02% 537

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ensign Peak Advisors's HCAT Position: Q1 2024 in Review

Ensign Peak Advisors sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 456,841 shares — an estimated $4.23M sold.

Ensign Peak Advisors first reported a position in HCAT in Q4 2019 and held it in 17 quarters. The position peaked at $24.5M in Q3 2021. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Ensign Peak Advisors reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 456,841 Health Catalyst shares in Q1 2024, an estimated $4.23M.
  • Ensign Peak Advisors first reported a position in Health Catalyst in Q4 2019 and held it in 17 quarters.
  • Ensign Peak Advisors's Health Catalyst position peaked at $24.5M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.